Elbasvir-Grazoprevir Zepatier
Glecaprevir-Pibrentasvir Mavyret
Ledipasvir-Sofosbuvir Harvoni
Ribavirin Copegus, Rebetol, Ribasphere
Sofosbuvir Sovaldi
Sofosbuvir-Velpatasvir Epclusa
Sofosbuvir-Velpatasvir-Voxilaprevir VoseviManagement of Cirrhosis-Related Complications
Recognition and Management of Spontaneous Bacterial Peritonitis
Section Navigation
Section Navigation
- Module 3 Overview
Management of Cirrhosis-Related Complications - 0%Lesson 1
Diagnosis and Management of AscitesActivities- 0%Lesson 2
Recognition and Management of Spontaneous Bacterial PeritonitisActivities- 0%Lesson 3
Screening for Varices and Prevention of BleedingActivity 2B. Role of Albumin in Treatment of SBP
Learning Objective Performance Indicators
- Explain the diagnostic criteria for spontaneous bacterial peritonitis
- Differentiate spontaneous bacterial peritonitis from secondary bacterial peritonitis
- Select appropriate antimicrobial therapy for persons with spontaneous bacterial peritonitis
- List indications for initiating primary and secondary bacterial peritonitis prophylaxis
- Discuss appropriate regimens for primary and secondary bacterial peritonitis prophylaxis
Instructions
Review the abstract of the article "Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis." The full free text is available, as well as the option to download a pdf of the article.Activity Question
You should answer this question after completing the activity.You must answer all of the questions before checking your work.
This activity has a Check on Learning question. - Show QuestionIn this randomized trial involving 126 patients with cirrhosis and spontaneous bacterial peritonitis, patients received either cefotaxime alone or cefotaxime plus intravenous albumin (1.5 g/kg at the time of diagnosis, followed by 1 g/kg on day 3).
Which one of the following statements best describes the impact of albumin in patients with cirrhosis and spontaneous bacterial peritonitis who are receiving therapy with cefotaxime?
Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
- 0%Lesson 2
Funded by
Centers for Disease Control and Prevention Cooperative Agreement (CDC-RFA-PS21-2105)
Created at
University of Washington
Part of
IDEA Platform
CME provided byUniversity of Alabama Birmingham
CNE provided byUniversity of Washington School of Nursing
Copyright © 2024 Hepatitis C Online
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhcvc-master-c8843673-2024-11-13-205624